Investment Lifecycle
Sourcing
Our goal is to be the first institutional investor that engages with a new company or group of individuals that is seeking to start a new company. Therefore, we meet a lot of teams who are in the very formative stages of considering a new business. It is never too early in the life cycle of your business to meet Delta Partners. Where we judge a business to have too many risk factors to warrant an investment by us at that time, we aim to provide some feedback on the risks or challenges facing the business. It often makes sense for us to meet with businesses a few times in their early life as they develop and the opportunity becomes clearer and more likely.
Our investment opportunities come from many sources:
- Spin-offs of development teams from international or locally owned technology companies.
- University spin-outs or campus companies.
- Entrepreneurially-minded people whom we meet through networking activities or who approach us directly.
- Former executives of previous technology start-ups.
We work with many different co-investors, many of which are UK-based and a number of which are based in Continental Europe and the United States.
Managing
First and foremost, we are investors rather than managers. Each of our partners handles multiple investments. Each company also has an independent management team, who run the business.
Therefore, we at Delta Partners seek to work with our companies by acting as board members and by engaging in very high leverage activities in combination with the executive team in each company. The areas in which we typically aim to help are: strategy formulation; new financing decisions and processes; executive hiring and team buidling; remuneration; and, selling the company or doing and IPO.
In summary, management steer the boat and we help plot the course.
Each investment is governed by a set of legal documents. While these documents can set out decision rights governing the company in great detail, we find that we rarely have disagreements with management over basic decision-making in the company.
Exits
One of the most important activities in the life of a company is the process of exiting. It is also one area where we can add significant value to the company, as we have been through a lot of exits whereas the entrepreneur will likely have limited or no experience.
We are firm believers in the maxim that companies are bought rather than sold. Generally, organised processes for selling a company only yield a high price if the process is initiated on the back of strong interest from one or more potential acquirers. Similarly, the public markets are only receptive to the strongest of stories, with proven busienss models and exceptional growth.
However, this presupposes that the groundwork for an exit has already been laid by the executive team in the years prior to the exit. Long before the exit process, the executive team needs to know all the possible acquirers and ensure they are familiar with the target company.
Among the positive exits we have benefited from are:
- Abacus Direct (IPO on Nasdaq, acquired by DoubleClick, Nasdaq: GOOG)
- County Media (sold to UTV, LON: UTV)
- Credo (sold to Misys, LON: MSY)
- Farran technology (sold to Smith Group, LON: SMIN)
- Pharmagene (IPO on LSE, merged with Asterand Inc, LON: ATD)
- Rogers (sold to P&O Group)
- Similarity Systems (sold to Informatica, Nasdaq: INFA)
- Toucan Technology (sold to PMC Sierra, Nasdaq: PMCS)
- Xiam (sold to Qualcomm, Nasdaq: QCOM)
Company News
- 23 April 2013:
SpineGuard raises €8.1 million ($10.5 million) in successful IPO... - 15 April 2013:
Ireland’s Genable Technologies Ltd secures Orphan Drug Designation by FDA for gene therapy product G... - 5 April 2013:
Qstream and Informa Training Partners Sign Partnership Agreement... - 5 March 2013:
Fixnetix Arrives in Canada... - 5 March 2013:
GLYSURE EARNS ISO 13485 CERTIFICATION... - 15 February 2013:
Miracor granted six additional patents for its PICSO® system... - 31 January 2013:
Digit raises US$2.5m led by Delta Partners to launch “Seamlessly Cross-Platform” games... - 28 January 2013:
Delta Partners nominated as Best Investor at the TNW Irish Startup Award... - 21 January 2013:
Fixnetix Offers Microwave Access between London and Frankfurt... - 10 January 2013:
Pricing Intelligence Firm Profitero To Provide Nielsen Clients With Online Competitor Pricing Audit... - 21 December 2012:
Xcelerator secures €1.2m in funding... - 17 December 2012:
Miracor’s PICSO® System is used for the first time under CE mark in UK... - 4 December 2012:
Miracor featured in December’s Journal of Interventional Cardiology... - 29 November 2012:
Glysure completes second closing... - 15 November 2012:
Fixnetix Deploys Market Data FPGA from NovaSparks for Asperatus Capital... - 12 November 2012:
Swrve to create 100 new jobs... - 1 November 2012:
Cleverbug wins 'best digital startup' at Eircom Spider Awards 2012... - 23 October 2012:
Spineguard featured in this month's issue of START-UP magazine... - 19 October 2012:
Interview with Cleverbug's Kealan Lennon on siliconrepublic.com... - 18 October 2012:
Cleverbug named as #14 of top 50 hottest Early Stage Startups at Dublin Web Summit... - 18 October 2012:
Delta invests in Cloudium Systems, a Limerick based technology firm... - 12 October 2012:
Delta Partners invests in Boxever a new cloud-based IT company in Dublin... - 24 September 2012:
Prepare PICSO study results published in Journal of Interventional Cardiology... - 31 August 2012:
Delta Partners Complete €2 Million Investment... - 30 August 2012:
Acceleron Selects QUMAS to Manage Regulatory Documents... - 30 August 2012:
The Next Web interviews WhipCar co-founder... - 30 August 2012:
Glucose Monitoring and the Economy... - 23 August 2012:
WhipCar co-founder presents at Media Evolution conference in Sweden... - 2 August 2012:
Glysure appoints Heidi Hausner as U.S director of Clinical Affairs... - 19 July 2012:
PediGuard® gives 30% reduction in radiation exposure... - 12 July 2012:
Glysure strengthens intellectual property portfolio with new patent and core technology acquisition... - 11 July 2012:
The Economist describes WhipCar's success... - 11 July 2012:
Benitec Biopharma signs key genetic eye disease licensing agreement with Genable Technologies... - 11 July 2012:
Neuravi welcomed to Delta's medtech portfolio... - 6 July 2012:
Miracor reports successful First-In-Man treatments using PICSO® system... - 25 June 2012:
Miracor granted several U.S. patents for its PICSO® system to treat severe heart attack patients... - 22 June 2012:
Spinal News International Profiles: Dr. Ciaran Bolger... - 21 June 2012:
RealBusines.com Profile: Peer-to-Peer Car Sharing Platform WhipCar... - 21 June 2012:
Kealan Lennon of Cleverbug featured in the Irish Times... - 29 May 2012:
Fixnetix Offers FPGA iX-eCute for Nanosecond Trading... - 24 May 2012:
Bloomberg Acquires PolarLake & Launches EDM Services... - 23 May 2012:
Private pursuits: Many banks are hoping that wealth management can restore their fortunes...
